by Entheon Biomedical | Apr 28, 2020 | Company News
https://www.benzinga.com/markets/cannabis/20/04/15838101/entheon-biomedical-ceo-timothy-ko-on-the-potential-of-psychedelics-in-addiction-treatment
by Entheon Biomedical | Apr 19, 2020 | Company News
https://www.benzinga.com/markets/cannabis/20/04/15836620/doubleblind-mag-weekly-recap-the-lsd-holiday-dmt-based-addiction-treatment-and-shrooms-vs-acid
by Entheon Biomedical | Apr 8, 2020 | Company News, Uncategorized
DMT (N-dimethyltryptamine) is known to occasion among the most intense of psychedelic experiences: For some it offers a blastoff into another dimension, an opportunity to “meet God”—or aliens. It can be transformative, mystical, or scary, but the effects only last...
by Entheon Biomedical | Apr 3, 2020 | Company News
This Startup is Developing a DMT-Based Addiction...
Recent Comments